prof. dr. P. (Peter) Heeringa

Professor

Research

  1. 2017
  2. 2016
  3. O'Reilly, V. P., Wong, L., Kennedy, C., Elliott, L. A., O'Meachair, S., Coughlan, A. M., ... Sanders, J. (2016). Urinary Soluble CD163 in Active Renal Vasculitis. Journal of the American Society of Nephrology, 27(9), 2906-2916. https://doi.org/10.1681/ASN.2015050511
  4. 2015
  5. Schaper, F., De Leeuw, K., Horst, G., Maas, F., Beijeren, D. V., Bijzet, J., ... Westra, J. (2015). Autoantibodies to high mobility group box 1 in patients with Incomplete and Systemic Lupus Erythematosus. 15. Abstract from 11th International Congress on Systemic Lupus Erythematosus, .
  6. Heeringa, P., & Stegeman, C. (2015). Pathogenesis of Vasculitis. In Oxford Textbook of Clinical Nephrology (4th ed.). Oxford University Press.
  7. 2014
  8. 2013
  9. Gonzalez, J., Mouttalib, S., Delage, C., Calise, D., Maoret, J-J., Pradere, J-P., ... Schanstra, J-P. (2013). Dual effect of chemokine CCL7/MCP-3 in the development of renal tubulointerstitial fibrosis. Biochemical and Biophysical Research Communications, 438(2), 257-263. https://doi.org/10.1016/j.bbrc.2013.07.025
  10. 2012

ID: 82042